MAYEROVÁ, Michaela, Libor USTOHAL, Jiří JARKOVSKÝ, Jan PIVNIČKA, Tomáš KAŠPÁREK and Eva ČEŠKOVÁ. Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations. Neuropsychiatric Disease and Treatment. Auckland: Dove Medical Press Ltd., 2018, vol. 14, No 2018, p. 1535-1543. ISSN 1178-2021. Available from: https://dx.doi.org/10.2147/NDT.S163839.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
Authors MAYEROVÁ, Michaela (203 Czech Republic, belonging to the institution), Libor USTOHAL (203 Czech Republic, guarantor, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jan PIVNIČKA (203 Czech Republic, belonging to the institution), Tomáš KAŠPÁREK (203 Czech Republic, belonging to the institution) and Eva ČEŠKOVÁ (203 Czech Republic, belonging to the institution).
Edition Neuropsychiatric Disease and Treatment, Auckland, Dove Medical Press Ltd. 2018, 1178-2021.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30215 Psychiatry
Country of publisher New Zealand
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.228
RIV identification code RIV/00216224:14110/18:00103968
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.2147/NDT.S163839
UT WoS 000435877800001
Keywords in English therapeutic drug monitoring; plasma levels; interindividual variability; schizophrenia; schizoaffective disorder
Tags 14110111, 14110222, 14119612, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 2/5/2019 14:02.
Abstract
Introduction: Therapeutic drug monitoring (TDM) of clozapine is a very useful method for verifying both the correct intake and the interindividual variability of its metabolism, thereby avoiding the risk of toxicity. The purposes of this paper were to discover how many patients using clozapine in common clinical practice have clozapine plasma concentration (PC) levels in the proposed reference range and to identify factors that influence clozapine PC levels. Methods: Our study included 100 inpatients (diagnosed with schizophrenia or schizoaffective disorder) taking standard doses of clozapine (100-700 mg/day). Clozapine concentration was measured by high-performance liquid chromatography. Correlations between doses and PC levels and the influence of smoking and gender on clozapine PC levels were calculated. Results: A large number of the patients (67%) had PC levels outside the proposed reference range. The clozapine PC levels were influenced by dose, gender, and cigarette smoking. Conclusion: The correlations between dose, gender, and cigarette smoking and clozapine PC levels highlighted by our study overlap other research. It was surprising to find such a large number of patients with clozapine PC levels outside the therapeutic range. This result suggests the importance of clozapine TDM due to misunderstood inter-and/or intraindividual variability or misestimated partial therapeutic compliance.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-31063A, research and development projectName: Buněčné markery vedoucí ke specifické léčbě "na míru" schizofrenním pacientům
PrintDisplayed: 27/4/2024 06:02